Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?
Saved in:
| Title: | Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms? |
|---|---|
| Authors: | Fernández-de-las-Peñas, César1,2 (AUTHOR) cesar.fernandez@urjc.es, Franco-Moreno, Anabel3 (AUTHOR) anaisabel.franco@salud.madrid.org, Ruiz-Ruigómez, María4 (AUTHOR) rryruiz@gmail.com, Arrieta-Ortubay, Estibaliz4 (AUTHOR) earrietao@gmail.com, Ryan-Murua, Pablo3,5 (AUTHOR) pabloryan@gmail.com, Lumbreras-Bermejo, Carlos4 (AUTHOR) carlos.lumbreras@salud.madrid.org, del-Valle-Loarte, Pablo6 (AUTHOR) pablo.valle@salud.madrid.org, Pellicer-Valero, Oscar J.7 (AUTHOR) oscar.pellicer@uv.es, Giordano, Rocco2,8 (AUTHOR) lan@hst.aau.dk, Arendt-Nielsen, Lars2,9,10 (AUTHOR), Martín-Garrido, Isabel11 (AUTHOR) isamartinga@gmail.com, Torres-Macho, Juan3,12 (AUTHOR) juan.torresm@salud.madrid.org |
| Source: | Viruses (1999-4915). Jun2024, Vol. 16 Issue 6, p947. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19994915 |
|---|---|
| DOI: | 10.3390/v16060947 |
